Bioabsorbable Drug-Eluting Stents May Solve Lingering Thrombosis Problem
This article was originally published in The Pink Sheet Daily
Executive Summary
Bioabsorbable stents could reduce the risk of chronic inflammation and thrombosis associated with permanent implants, be better suited for pediatric applications, expert suggests at recent CRT conference. Boston Scientific/Riva Medical, Guidant, Biotronik and Biosensors all have bioabsorbable stent projects underway.